Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2023-08-15 Investor Presentation
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
112年08月法人說明會簡報 — 179520230815E001.pdf
Investor Presentation Classification · 95% confidence The document is titled '2023 Q2 EARNINGS RESULTS Investor Presentation' and contains detailed financial results for the second quarter of 2023, including revenue, net income, EPS, segment performance, and business highlights. It includes forward-looking statements, business development updates, pipeline execution, and financial highlights with actual financial data. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The content is consistent with an investor presentation focusing on quarterly financial results, business strategy, and market position. Therefore, the document fits the category of an Investor Presentation (IP).
2023-08-15 Chinese
112年08月法人說明會簡報 — 179520230815M001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2023 Q2 Operational Results Report Investor Report" and contains detailed financial results for the second quarter and first half of 2023, including revenue, gross profit, net profit, and EPS figures. It also includes extensive operational highlights, product development updates, market expansion strategies, and R&D progress. The content is comprehensive and includes actual financial data and analysis for a specific interim period (Q2 2023). There is no indication that this is merely an announcement or a presentation; rather, it is a detailed report covering quarterly financial performance and business updates. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2023
2023-08-15 Chinese
112年08月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing scheduled dates and details for corporate investor presentations (法人說明會) including times, locations, and links to presentation materials and webcast URLs. The content focuses on announcements of investor meetings and presentations rather than the full financial reports or transcripts. The presence of presentation PDFs and webcast links indicates these are investor presentations. The document length is short (1184 characters) and it is essentially an announcement or schedule of investor presentations, not the presentations themselves or detailed financial reports. Therefore, the most appropriate classification is Investor Presentation (IP).
2023-08-15 Chinese
112年第2季海外子公司投資
Interim / Quarterly Report Classification · 85% confidence The document contains detailed financial data about investments in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for the current period and previous year-end. The data is presented in a tabular format with notes explaining accounting treatments. The document length is 2491 characters, which is relatively short but contains substantive financial data rather than just an announcement or certification. There is no indication that this is a full annual or interim report, nor is it a simple announcement or certification. The content aligns with detailed financial disclosures typically found in an Interim / Quarterly Report (IR), as it provides period-specific financial information and analysis on investments. Therefore, the document is best classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-13 Chinese
112年第2季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory limits. The content is focused on investment details rather than a full financial report or announcement. The document length is short (1439 characters), but it contains substantive financial data related to investments, not just an announcement or certification. This type of disclosure aligns with regulatory filings related to investment information rather than a full annual or interim report. Given the nature and format, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-08-13 Chinese
112年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables labeled as "合併權益變動表" which translates to "Consolidated Statement of Changes in Equity." It includes financial data for the first half of the year 2023 (民國112年上半年度) and the same period of the previous year. The data includes equity components such as common stock, capital surplus, legal reserve, special reserve, undistributed earnings, and other comprehensive income items. The presence of detailed financial data for a half-year period indicates this is a substantive financial report covering a period shorter than a full fiscal year. The document length is 4412 characters, which is sufficient to contain actual financial data rather than just an announcement. There is no indication that this is an announcement or a certification. Therefore, this document is best classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.